|
1
|
Nordlund J, Bäcklin CL, Wahlberg P, Busche
S, Berglund EC, Eloranta ML, Flaegstad T, Forestier E, Frost BM,
Harila-Saari A, et al: Genome-wide signatures of differential DNA
methylation in pediatric acute lymphoblastic leukemia. Genome Biol.
14:r1052013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Loghavi S, Kutok JL and Jorgensen JL:
B-acute lymphoblastic leukemia/lymphoblastic lymphoma. Am J Clin
Pathol. 144:393–410. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pui CH, Yang JJ, Hunger SP, Pieters R,
Schrappe M, Biondi A, Vora A, Baruchel A, Silverman LB, Schmiegelow
K, et al: Childhood acute lymphoblastic leukemia: Progress through
collaboration. J Clin Oncol. 33:2938–2948. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cooper SL and Brown PA: Treatment of
pediatric acute lymphoblastic leukemia. Haematologica.
93:1124–1128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pui CH, Carroll WL, Meshinchi S and Arceci
RJ: Biology, risk stratification, and therapy of pediatric acute
leukemias: An update. J Clin Oncol. 29:551–561. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Harrison CJ: Cytogenetics of paediatric
and adolescent acute lymphoblastic leukaemia. Br J Haematol.
144:147–156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arico M, Schrappe M, Hunger SP, Carroll
WL, Conter V, Galimberti S, Manabe A, Saha V, Baruchel A,
Vettenranta K, et al: Clinical outcome of children with newly
diagnosed philadelphia chromosome-positive acute lymphoblastic
leukemia treated between 1995 and 2005. J Clin Oncol. 28:4755–4761.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mullighan CG, Goorha S, Radtke I, Miller
CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds
SB, et al: Genome-wide analysis of genetic alterations in acute
lymphoblastic leukaemia. Nature. 446:758–764. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mullighan CG, Su X, Zhang J, Radtke I,
Phillips LA, Miller CB, Ma J, Liu W, Cheng C, Schulman BA, et al:
Deletion of IKZF1 and prognosis in acute lymphoblastic
leukemia. N Engl J Med. 360:470–480. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nebbioso A, Tambaro FP, Dell'Aversana C
and Altucci L: Cancer epigenetics: Moving forward. PLoS Genet.
14:e10073622018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burke MJ and Bhatla T: Epigenetic
modifications in pediatric acute lymphoblastic leukemia. Front
Pediatr. 2:422014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Davidsson J, Lilljebjörn H, Andersson A,
Veerla S, Heldrup J, Behrendtz M, Fioretos T and Johansson B: The
DNA methylome of pediatric acute lymphoblastic leukemia. Hum Mol
Genet. 18:4054–4065. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Esteller M: Epigenetic gene silencing in
cancer: The DNA hypermethylome. Hum Mol Genet. 1:R50–R59. 2007.
View Article : Google Scholar
|
|
14
|
Hale V, Hale GA, Brown PA and Amankwah EK:
A review of DNA methylation and microRNA expression in recurrent
pediatric acute leukemia. Oncology. 92:61–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Navarrete-Meneses MDP and Pérez-Vera P:
Epigenetic alterations in acute lymphoblastic leukemia. Bol Med
Hosp Infant Mex. 74:243–264. 2017.(In Spanish). PubMed/NCBI
|
|
16
|
Stumpel DJ, Schneider P, van Roon EH, Boer
JM, de Lorenzo P, Valsecchi MG, de Menezes RX, Pieters R and Stam
RW: Specific promoter methylation identifies different subgroups of
MLL-rearranged infant acute lymphoblastic leukemia, influences
clinical outcome, and provides therapeutic options. Blood.
114:5490–5498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Borssén M, Palmqvist L, Karrman K,
Abrahamsson J, Behrendtz M, Heldrup J, Forestier E, Roos G and
Degerman S: Promoter DNA methylation pattern identifies prognostic
subgroups in childhood T-cell acute lymphoblastic leukemia. PLoS
One. 8:e653732013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Borssén M, Haider Z, Landfors M,
Norén-Nyström U, Schmiegelow K, Åsberg AE, Kanerva J, Madsen HO,
Marquart H, Heyman M, et al: DNA methylation adds prognostic value
to minimal residual disease status in pediatric T-cell acute
lymphoblastic leukemia. Pediatr Blood Cancer. 63:1185–1192. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amigou A, Rudant J, Orsi L, Goujon-Bellec
S, Leverger G, Baruchel A, Bertrand Y, Nelken B, Plat G, Michel G,
et al: Folic acid supplementation, MTHFR and MTRR
polymorphisms, and the risk of childhood leukemia: The ESCALE study
(SFCE). Cancer Causes Control. 23:1265–1277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duthie SJ, Narayanan S, Blum S, Pirie L
and Brand GM: Folate deficiency in vitro induces uracil
misincorporation and DNA hypomethylation and inhibits DNA excision
repair in immortalized normal human colon epithelial cells. Nutr
Cancer. 37:245–251. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Refsum H, Wesenberg F and Ueland PM:
Plasma homocysteine in children with acute lymphoblastic leukemia:
Changes during a chemotherapeutic regimen including methotrexate.
Cancer Res. 51:828–835. 1991.PubMed/NCBI
|
|
22
|
Pinnix CC, Chi L, Jabbour EJ, Milgrom SA,
Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, et al:
Dorsal column myelopathy after intrathecal chemotherapy for
leukemia. Am J Hematol. 92:155–160. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Metayer C, Milne E, Dockerty JD, Clavel J,
Pombo-de-Oliveira MS, Wesseling C, Spector LG, Schüz J, Eleni P,
Sameera E, et al: Maternal supplementation with folic acid and
other vitamins and risk of leukemia in the offspring: A childhood
leukemia international consortium study. Epidemiology. 25:811–822.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brunaud L, Alberto JM, Ayav A, Gérard P,
Namour F, Antunes L, Braun M, Bronowicki JP, Bresler L and Guéant
JL: Effects of vitamin B12 and folate deficiencies on DNA
methylation and carcinogenesis in rat liver. Clin Chem Lab Med.
41:1012–1019. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu M and Li Z: Interpretation of the
recommendations for the diagnosis and treatment of children with
acute lymphocytic leukemia (four revisions). Chin J Pediatr.
52:645–648. 2014.
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sambrook J and Russell DW: Preparation and
analysis of eukaryotic genomic DNA (Chapter 6). Molecular Cloning -
A Laboratory Manual. 1. 3rd. Cold Spring Harbor Laboratory Press;
New York, NY: pp. 4–12. 2001
|
|
28
|
Popp C, Dean W, Feng S, Cokus SJ, Andrews
S, Pellegrini M, Jacobsen SE and Reik W: Genome-wide erasure of DNA
methylation in mouse primordial germ cells is affected by AID
deficiency. Nature. 463:1101–1105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Iacobucci I and Mullighan CG: Genetic
basis of acute lymphoblastic leukemia. J Clin Oncol. 35:975–983.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Z, Karaplis AC, Ackerman SL, Pogribny
IP, Melnyk S, Lussier-Cacan S, Chen MF, Pai A, John SW, Smith RS,
et al: Mice deficient in methylenetetrahydrofolate reductase
exhibit hyperhomocysteinemia and decreased methylation capacity,
with neuropathology and aortic lipid deposition. Hum Mol Genet.
10:433–444. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Seremak-Mrozikiewicz A, Bogacz A,
Bartkowiak-Wieczorek J, Wolski H, Czerny B, Gorska-Paukszta M and
Drews K: The importance of MTHFR, MTR, MTRR and CSE expression
levels in Caucasian women with preeclampsia. Eur J Obstet Gynecol
Reprod Biol. 188:113–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guest EM and Stam RW: Updates in the
biology and therapy for infant acute lymphoblastic leukemia. Curr
Opin Pediatr. 29:20–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Guise CP, Dachs GU, Phung Y, Hsu
AH, Lambie NK, Patterson AV and Wilson WR: Identification of
one-electron reductases that activate both the hypoxia prodrug
SN30000 and diagnostic probe EF5. Biochem Pharmacol. 91:436–446.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wong NC, Meredith GD, Marnellos G, Dudas
M, Parkinson- Bates M, Halemba MS, Chatterton Z, Maksimovic J,
Ashley DM, Mechinaud F, et al: Paediatric leukaemia DNA methylation
profiling using MBD enrichment and SOLiD sequencing on archival
bone marrow smears. Gigascience. 4:112015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Court EL, Davidson K, Smith MA, Inman L,
Marriott SA, Smith JG and Pallister CJ: C-kit mutation screening in
patients with acute myeloid leukaemia: Adaptation of a
Giemsa-stained bone-marrow smear DNA extraction technique. Br J
Biomed Sci. 58:76–84. 2001.PubMed/NCBI
|
|
36
|
Dubbs SB: Rapid Fire: Tumor lysis
syndrome. Emerg Med Clin North Am. 36:517–525. 2018. View Article : Google Scholar : PubMed/NCBI
|
